(Q40361357)

19 September 2017

title

Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997-2007. (English)

1 reference

19 September 2017

1 reference

cryptococcal meningitis

1 reference

Li-Ping Zhu

1

1 reference

19 September 2017

Ji-Qin Wu

2

1 reference

19 September 2017

Bin Xu

3

1 reference

19 September 2017

Xue-Ting Ou

4

1 reference

19 September 2017

Qiang-Qiang Zhang

5

1 reference

19 September 2017

Xin-Hua Weng

6

1 reference

19 September 2017

publication date

1 June 2010

1 reference

19 September 2017

1 reference

19 September 2017

volume

48

1 reference

19 September 2017

issue

4

1 reference

19 September 2017

page(s)

570-579

1 reference

The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Epidemiology and management of cryptococcal meningitis: developments and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Cryptococcosis in solid organ transplant recipients: current state of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Prognostic factors in cryptococcal meningitis. A study in 111 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Cryptococcosis in human immunodeficiency virus-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Cryptococcal meningitis in non-HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Management of cryptococcosis in non-HIV-related patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

21 January 2018

Cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Cerebral cryptococcosis in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693780903437876

10.3109/13693780903437876

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference